Hospital for Special Surgery (HSS) announced the appointment of Matthew T. Drake, MD, PhD, as chief of the Division of Endocrinology and director of the Metabolic Bone Service.
Drake has been a consultant in the Division of Endocrinology, Diabetes, Metabolism, and Nutrition at the Mayo Clinic in Rochester, Minn., since 2007. He assumed a dual role as a consultant in Mayo Clinic’s Division of Hematology in 2017. He has been an associate professor of medicine at the Mayo Clinic College of Medicine and Science since 2015.
Drake will ensure the continued excellence of the clinical, educational, and investigative programs in the Division of Endocrinology and the Metabolic Bone Service. He will work with HSS physicians and staff to optimize quality, the patient experience and outcomes. His role will include collaboration with internists and orthopedic surgeons at HSS, particularly those focused on joint replacement, sports medicine and spine, to identify and address risk factors related to bone health that could affect surgical outcomes.
“With its outstanding reputation for providing the highest standards of care, passion for excellence and innovation, and strong commitment to improving the lives of patients everywhere, it is an honor and a privilege to join HSS,” says Drake. “I look forward to working closely with the clinical and research staff and collaborating with a highly motivated team of specialized faculty to achieve our best musculoskeletal health outcomes.”
The recipient of numerous research grants from the National Institutes of Health, Drake will play a key role in the internationally recognized research programs at HSS, collaborating with leaders of the HSS Research Institute, the Department of Orthopedics and the Division of Rheumatology, to define priorities for investigation.
Drake’s own research has focused on the underlying mechanisms and skeletal changes related to age-related bone loss. He has also sought to better understand how cancer affects bone health. Drake believes that unraveling the mysteries of how normal aging or the presence of malignancies leads to the softening or destruction of bone mass could ultimately lead to new or improved methods to prevent and treat bone loss.
His research has been featured in 125 peer-reviewed articles, and he has written 11 book chapters on topics that include the pathogenesis of osteoporosis, myeloma bone disease, and disorders of calcium and bone metabolism.
Drake graduated Magna Cum Laude from Harvard College, where he received an AB degree in Biology. He attended Washington University earning his MD degree in addition to a PhD in Molecular and Cell Biology. He went on to an Internal Medicine/Endocrinology residency at Duke University Medical Center, where he also completed a clinical research fellowship. His academic accomplishments include a second clinical research fellowship in Endocrinology at the Mayo Clinic College of Medicine.
Loading ...